CRMD vs SONY
CorMedix Inc (CRMD) versus SONY (SONY) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
SONY (SONY) common stock.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
SONY does not have a complete income-statement cache yet.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. SONY currently screens at market cap $0.
Not investment advice. Open the CRMD and SONY stock pages for the full models.
Not investment advice.